Get In Touch
Have any questions or comments about the content you see on this page?
Our News
February 29, 2024
We are very proud to share that Alnylam has achieved a score of 90 out of 100 on the Human Rights Campaign's (HRC) 2023-2024 Corporate Equality Index (CEI) based on our US policies, practices, and benefits from an LGBTQ+ perspective. This was Alnylam’s first time applying to the HRC’s CEI and the accomplishment reflects our ongoing commitment to fostering a diverse, inclusive, and equitable workplace for all employees.
The HRC’s CEI - which is published annually - is a prestigious benchmarking tool that evaluates corporate policies and practices related to LGBTQ+ workplace equality, benefits and protections.
We hope to continue to build upon this success and find new ways to promote equality and inclusion within our organization and beyond. I am incredibly proud of Alnylam and our SAGA employee resource network for their efforts in creating a workplace that not only celebrates diversity but also actively champions human rights in all forms.” – Tolga Tangular, Chief Commercial Officer and SAGA Co-Executive Sponsor
Click here to learn more about how Alnylam scored on each of the HRC’s rating criteria, which includes Workforce Protections, Inclusive Benefits, Internal Training/Inclusive Culture, and Corporate Social Responsibility.
We invite you to learn more about Alnylam's approach to diversity, equity and inclusion, and explore our culture and career opportunities.
Responsibility, Articles, DE&I, Gender Equality, Our Culture, Careers
Have any questions or comments about the content you see on this page?
The following content may not be associated with Alnylam Pharmaceuticals.
Links to all outside sites are provided as a reference for our visitors.
Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.
Proceed to Site